DJIA 18,010.68 -115.44 -0.64%
NASDAQ 5,070.03 -27.95 -0.55%
S&P 500 2,107.39 -13.40 -0.63%
market minute promo

Pfizer (NYSE: PFE)

34.75 0.31 (0.90%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

PFE $34.75 0.90%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $34.48
Previous Close $34.44
Daily Range $34.41 - $34.99
52-Week Range $27.51 - $35.53
Market Cap $214.0B
P/E Ratio 23.92
Dividend (Yield) $1.12 (3.3%)
Ex-Dividend Date
Dividend Pay Date
Volume 50,075,294
Average Daily Volume 23,151,602
Current FY EPS $2.04




Drug Makers

Pfizer (PFE) Description

A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra. Website:

News & Commentary Rss Feed

Pfizer's Monstrous Clinical Pipeline Is Harboring 2 Hidden Gems

Pfizer's mind-boggling size often results in promising clinical candidates getting swept under the rug, so to speak. Here is a look at two of the pharma giant's orphan drug candidates that haven't generated much talk among investors, despite being potential game-changers for their target indications.

10 American Companies That Pull in the Most Cash

Let's measure something that's better than "profitability."

Viagra Maker Pfizer Keeps Boosting Dividends

4 Stocks Eagle Asset Management Has Been Buying

It can pay off to keep an eye on what the big investors are doing.

Is A Big Acquisition Is Due For Pfizer?

Pfizer (PFE) Stock Gaining on Rare Lung Disorder Treatment Approval

Veeva Beats Q1 Earnings on Strong Revenues, Stock Down - Analyst Blog

Dogs Of The Dow Were Well Behaved In April

3 Health Care Stocks On The Rise

S&P 500 Index Futures Trading Lower In Volatile Trading

See More PFE News...

PFE's Top Competitors

PFE $34.75 (0.90%)
Current stock: PFE
JNJ $100.14 (-1.00%)
Current stock: JNJ
ROG $72.25 (-0.03%)
Current stock: ROG
GSK $44.37 (-0.94%)
Current stock: GSK